Abstract:Normal liver dose is of paramount in liver SBRT due to the risk of radiation induced liver disease (RILD). In our clinic, the generalized equivalent uniform dose (gEUD) of normal liver (liver-GTV) is used to determine if a prescription (Rx) needs to be deescalated (e.g., from 50 to 45 Gy) to limit the risk of RILD. To estimate the normal liver gEUD, a planner often needs to create a preliminary plan with full Rx. The goal of this work was to build a machine learning model using artificial neural network trained with our prior SBRT patients to predict normal liver gEUD purely using the geometric properties of liver and PTV, to eliminate the need for the preliminary plan. The initial model was trained by 40 consecutive liver SBRT patients treated in our clinic from December 2014 to February 2018 meeting the following criteria: (1) 50 Gy in 5 or 6 fractions, (2) single-lesion IMRT or VMAT plan created using multi-criteria optimization (MCO), (3) no prior radiation or no dosimetric impact from any prior radiation, and (4) 98% of GTV covered by >50 Gy. An A value of 0.9 was used to calculate the gEUD of normal liver (excluding GTV). The artificial neural network consisted of five layers including three hidden ones. It used six inputs: the x, y, and z coordinate of the center of PTV relative to the center of total liver (including GTV), the distance between the two centers, and the volume of the PTV and total liver. The model was tested on new consecutive patients since February 2018. Since the model is bounded to input ranges, a new patient with input outside the initial range cannot be used test the model. For this reason, five new patients were added to the learning data before ten qualified new patients were found to test the model. All training and test patients were treated on two different linear accelerators, both with 5-mm leaves in central 20×20 cm2 field. The model accurately predicted normal liver gEUD for five patients, with an error of <3.2% (<0.35 Gy). For the other five, the error ranged from 7.9% to 12.9% (0.76 to 1.33 Gy). On average, the error was -0.8±8.4% (-0.14±0.98 Gy). The error increased when any input approached the limit in the under-sampled boundary region. For the patient with the largest error, the x of PTV center was -7.23 cm, only 0.08 cm away from the lower limit. For the patient with the second largest error, the y of PTV center was 7.16 cm, only 0.75 cm away from the upper limit. The model will become more robust once it learns from those patients with inputs in the boundary regions. The calculation for a new patient takes <1 second on a regular PC. The model can be exported as a Python function and scripted in common contouring and planning systems. A machine learning model was built to predict normal liver gEUD in 50-Gy liver SBRT, only using the geometric properties of liver and PTV. The prediction was within 13% (1.3 Gy) of the actual value for ten consecutive prospective patients. The model can facilitate the Rx selection in liver SBRT, promoting efficiency for planners and clinicians.

Uninvolved Liver Dose Prediction in Stereotactic Body Radiation Therapy for Liver Cancer Based on the Neural Network Method

A Machine-Learning Model Using Artificial Neural Network to Facilitate Liver SBRT Prescription Selection by Predicting Normal Liver Geud Based on Geometric Properties of Liver and PTV

Neutrophil-lymphocyte Ratio As a Prognostic Factor for Stereotactic Body Radiotherapy Treatment of Metastatic Liver Tumors.

Automated Clinical Target Volume Delineation Using Deep 3D Neural Networks in Radiation Therapy of Non-small Cell Lung Cancer

A Neural Network-based Method for Predicting Dose to Organs at Risk in Intensity-modulated Radiotherapy for Nasopharyngeal Carcinoma

Prediction of dose distributions for non‐small cell lung cancer patients using MHA‐ResUNet

Neural network dose models for knowledge-based planning in pancreatic SBRT

Prediction of radiation induced liver disease using artificial neural networks.

A data-driven approach to optimal beam/arc angle selection for liver stereotactic body radiation therapy treatment planning

A deep learning model to predict dose-volume histograms of organs at risk in radiotherapy treatment plans

Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy

Using deep learning to model the biological dose prediction on bulky lung cancer patients of partial stereotactic ablation radiotherapy

Use of a neural network-based prediction method to calculate the therapeutic dose in boron neutron capture therapy of patients with glioblastoma

Predicting voxel-level dose distributions of single-isocenter volumetric modulated arc therapy treatment plan for multiple brain metastases

Prediction on radiation-induced liver disease with an artificial neural network model

Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method

Prediction of Three-Dimensional Radiotherapy Optimal Dose Distributions for Lung Cancer Patients with Asymmetric Network

Automatic Treatment Planning Based on Three-Dimensional Dose Distribution Predicted from Deep Learning Technique.

Enhancing stereotactic ablative boost radiotherapy dose prediction for bulky lung cancer: A multi‐scale dilated network approach with scale‐balanced structure loss

Dosimetric Study of Deep Learning-Guided ITV Prediction in Cone-beam CT for Lung Stereotactic Body Radiotherapy

Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular Carcinoma